Загрузка...
Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
Colorectal cancer (CRC) is the third most common cancer worldwide. Even if 5‐fluorouracil (5‐FU) is used as the first‐line chemotherapeutic drug, responsiveness is only 20‐30%. Acquired resistance to 5‐FU contributes to both poor patient prognosis and relapse, emphasizing the need to identify biomar...
Сохранить в:
| Опубликовано в: : | J Cell Mol Med |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810928/ https://ncbi.nlm.nih.gov/pubmed/33325631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15752 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|